This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
New spending habits require responsive budgeting. Implement flexible rules that accommodate changes while protecting savings and debt targets.
25,665 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
A new partnership could let borrowers pledge crypto as collateral for home loans. This article breaks down how crypto...
Two popular small-cap ETFs battle for attention: IJR and ISCB. This guide breaks down how they differ, the costs, ris...
In 2026, investors face a crowded field of passive options. This guide breaks down index funds and ETFs, reveals when...
A new breed of risk is gnawing at fixed-income markets: opaque AI lending and leveraged credit create unseen damage t...
Progressive and Lemonade sit at opposite ends of the insurance spectrum in 2026. This guide breaks down their models,...
Stocks drift with a quiet S&P 500 backdrop while volatility concentrates in single stocks. The market faces asymmetri...
When cloud stocks tumble, two giants stand out as potential bargains. This guide breaks down whether Oracle or Salesf...
Bitcoin and wider crypto markets are eyeing a massive options expiry as traders lean into volatility bets. The option...
The FIFA World Cup is fueling a new wave of activity in prediction markets. Kalshi is riding that momentum, turning t...
A decade can dramatically change a portfolio. This article explores how you'd invested $10,000 Walmart ten years ago ...
A single bullish call can spark excitement, but savvy investors know that big upside ideas demand rigorous scrutiny. ...